InvestorsHub Logo

Vegas Stocks

06/28/20 7:02 AM

#88146 RE: Amatuer17 #88145

Yes, obviously. We are talking about if things go right for us & approval is a big part of that scenario. I agree

Dieselpro

06/28/20 9:01 AM

#88152 RE: Amatuer17 #88145

The trial is to show efficiency, eIND show amazing results how would that only be 30% chance? I think you're way off. I put it at 95% chance of approval. And as far as manufacturing, the day they get that approval it's now a multi billion dollar winning lottery ticket. They will have multiple deals for manu. I'm almost sure they already have multiple in place right now that we don't even know about.

justdafactss

06/28/20 9:15 AM

#88153 RE: Amatuer17 #88145

Yep 30% or less sounds about right.

CYDY insiders (CEO, CFO and Directors) stuffing their pockets NOW (see filings) while the next tout is being prepped for release-

Other Possibilities

There is, for example, interest in a 400-patient trial of leronlimab for Alzheimer's. I heard talk of the blood brain barrier, but I do not understand the method of action here. Presumably, cytokines and chemokines may be creating mischief in the brain - inflammation, but without further explanation, I would not make this my reason to buy CYDY.


https://seekingalpha.com/article/4355694-dont-forget-cytodyns-prospects